Relationship between severity of prevalent vertebral fractures and risk of subsequent nonvertebral fractures in postmenopausal women with osteoporosis: Results from the more trial

被引：0
|
作者：
Delmas, PD
Genant, H
Crans, G
Stock, J
Wong, M
Siris, E
Adachi, J
机构：
[1] Univ Lyon 1, Hop Edouard Herriot, F-69365 Lyon, France
[2] Univ Calif San Francisco, Osteoporosis & Arthritis Res Grp, San Francisco, CA 94143 USA
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[4] Columbia Univ, Dept Med, New York, NY USA
[5] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：316 / 316
页数：1
相关论文
共 50 条
  • [21] Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent
    Kim, S. H.
    Choi, H. S.
    Rhee, Y.
    Kim, K. J.
    Lim, S-K.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (03) : 781 - 787
  • [22] Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent
    S. H. Kim
    H. S. Choi
    Y. Rhee
    K. J. Kim
    S.-K. Lim
    Osteoporosis International, 2011, 22 : 781 - 787
  • [23] Inverse relationship between vertebral fractures and spine osteoarthritis in postmenopausal women with osteoporosis
    Roux, C.
    Fechtenbaum, J.
    Briot, K.
    Cropet, C.
    Liu-Leage, S.
    Marcelli, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) : 224 - 228
  • [24] SEVERE PREVALENT VERTEBRAL FRACTURES PREDICT SUBSEQUENT VERTEBRAL AND NONVERTEBRAL FRACTURES: A 3-YEAR PROSPECTIVE STUDY
    Bruyere, O.
    Roux, C.
    Nicolet, D.
    Fechtenbaum, J.
    Deroisy, R.
    Reginster, J. Y.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S361 - S362
  • [25] Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis
    Delmas, PD
    BONE, 2002, 30 (01) : 14 - 17
  • [26] Strontium ranelate reduces the risk of vertebral fractures in osteoporotic postmenopausal women with multiple prevalent vertebral fractures
    Ortolani, S
    Fechtenbaum, J
    Devogelaer, J
    Cannata, J
    Bonidan, O
    Hensen, J
    Roux, C
    Meunier, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 93 - 93
  • [27] ABALOPARATIDE FOR RISK REDUCTION OF NONVERTEBRAL AND VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS: AN UPDATED NETWORK META-ANALYSIS
    Reginster, J. -Y.
    Bianic, F.
    Campbell, R.
    Martin, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S49 - S49
  • [28] The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis: 4-year results from the MORE Trial.
    Eastell, R
    Adachi, J
    Harper, K
    Sarkar, S
    Delmas, PD
    Ensrud, K
    Gennari, C
    Reginster, JY
    Pols, H
    Recker, R
    Harris, S
    Wu, W
    Genant, H
    Black, D
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S229 - S229
  • [29] SIFRAR -: An original score to assess risk of prevalent vertebral fractures in postmenopausal women:: Preliminary results
    Goncalves, S
    Arias, MA
    Cachizumba, MO
    Agüero, RG
    Volta, SM
    Gallo, RA
    Massari, FEG
    Zanchetta, JR
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S63 - S63
  • [30] Risk factors associated with incident clinical vertebral and nonvertebral fractures in postmenopausal women: the Canadian Multicentre Osteoporosis Study (CaMos)
    Papaioannou, A
    Joseph, L
    Ioannidis, G
    Berger, C
    Anastassiades, T
    Brown, JP
    Hanley, DA
    Hopman, W
    Josse, RG
    Kirkland, S
    Murray, TM
    Olszynski, WP
    Pickard, L
    Prior, JC
    Siminoski, K
    Adachi, JD
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (05) : 568 - 578
12345